Inventor · disambiguated record
Soren Bjorn
Also filed as: BJOERN SOEREN · BJORN SOREN · BJORN SOREN E · BJORN SOREN ERIK
4 granted patents·25 pending applications·157 citations·filing 1994–2009
79Inventor score
Files withNOVO NORDISK AS6NOVO NORDISK HEALTHCARE AG3KNUDSEN LISELOTTE B2THIM LARS2FLODGAARD HANS J1
Top patents by PatentIndex Score
29 records- 0195US8097698B2Derivatives of GLP-1 analogsKNUDSEN LISELOTTE BJERRE·Filed 2007·Granted Jan 17, 2012·59 cites·15 claims
- 0287US5395922AYeast processing systemNOVO NORDISK AS·Filed 1994·Granted Mar 7, 1995·93 cites·46 claims
- 0380US8053410B2Pegylated factor VII glycoformsNOVO NORDISK HEALTH CARE A G·Filed 2009·Granted Nov 8, 2011·4 cites·2 claims
- 0473US2008274964A1Human Spasmolytic Polypeptide in Glycosylated FormNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 0567US2009011461A1Human Spasmolytic Polypeptide in Glycosylated FormNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 0665US7033609B2Microparticle preparationJAGOTEC AG·Filed 2002·Granted Apr 25, 2006·1 cites·12 claims
- 0765US2006019881A1Human spasmolytic polypeptide in glycosylated formTHIM LARS·Filed 2005·Application pending·0 cites
- 0864US2006199763A1Derivatives of GLP-1 analogsKNUDSEN LISELOTTE B·Filed 2004·Application pending·0 cites
- 0964US2010028939A1Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic InterestNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1064US2005287640A1Human spasmolytic polypeptide in glycosylated formTHIM LARS·Filed 2005·Application pending·0 cites
- 1163US2008045450A1GLP-2 DerivativesKNUDSEN LISELOTTE B·Filed 2006·Application pending·0 cites
- 1259US2008039373A1Pegylated Factor VII GlycoformsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1358US2006198819A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1456US2003077696A1Human spamolytic polypeptide in glycosylated formFiled 2000·Application pending·0 cites
- 1555US2006024730A1TF binding compoundsNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 1652US2004127418A1GLP-2 derivativesFiled 2003·Application pending·0 cites
- 1750US2004072755A1TF antagonistFiled 2003·Application pending·0 cites
- 1850US2004110929A1TF binding compoundFiled 2003·Application pending·0 cites
- 1949US2007179096A1Pharmaceutical FormulationNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2049US2008279856A1Inhibition of Bradykinin ReleaseNOVO NORDISK PHARMACEUTICALS I·Filed 2007·Application pending·0 cites
- 2149US2005113565A1Pegylated factor VII glycoformsFiled 2003·Application pending·0 cites
- 2247US2002025933A1GLP-2 derivativesFiled 2001·Application pending·0 cites
- 2346US2003096752A1Aprotinin variants having improved propertiesFiled 2002·Application pending·0 cites
- 2444US2003162711A1Pharmaceutical formulationFiled 2003·Application pending·0 cites
- 2544US2002151472A1TFF peptidesFiled 2001·Application pending·0 cites
- 2643US2006154319A1Inhibition of bradykinin releaseFLODGAARD HANS J·Filed 2005·Application pending·0 cites
- 2740US2006205036A1Coagulation Factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2832US2006018831A1TF binding agent and use thereofH S RIGSHOSPITALET·Filed 2005·Application pending·0 cites
- 2922US2002077461A1Pharmaceutical formulationFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Soren Bjorn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →